Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

Among Zimmer Biomet’s knee solutions being featured at the AAOS ... Meanwhile, the Persona IQ 30 mm Stem demonstrates how smart technology can enhance post-operative monitoring with real-time ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component, Persona Revision SoluTion Femur, to provide an option for individuals ...

Zimmer Biomet ZBH is gaining from expansion ... The fourth pillar will focus on the development of the world's first and only Smart Knee- Persona iQ, which is still in limited launch per its ...

Zimmer Biomet Holdings, Inc. (ZBH), Friday announced that the company has received the U.S. Food and Drug Administration 510(k) clearance of Persona Revision SoluTion Femur, a revision knee ...

The Smart Orthopedic Implants market is expected to grow from an estimated USD 26.21 Billion in 2024 to USD 40.66 Billion in ...

Zimmer originally took the walking frame invented ... It has introduced the world’s first and only “smart” knee implant (it tracks a patient’s walking speed and step count), as well ...

Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona® Revision SoluTion™ Femur, and Debut of ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...